Taysha Gene Therapies, Inc. TSHA Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s change in other assets?
- Taysha Gene Therapies, Inc. (TSHA) reported change in other assets of $794K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s change in other assets changed year-over-year?
- Taysha Gene Therapies, Inc.'s change in other assets decreased by 24.5% year-over-year, from $1.05M to $794K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s change in other assets?
- Over 2 years (2022 to 2024), Taysha Gene Therapies, Inc.'s change in other assets has grown at a -69.9% compound annual growth rate (CAGR), from -$2.28M to -$207K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.